Create an account
Enter your password
Gold's Rally Hoists Triple Flag Despite Production Hurdles
Convincing the market that Triple Flag can translate higher metal prices into sustained earnings seems to be a tough task.
Verbund: 3Q26 runs dry, but 2027 hedges and a court challenge offer upside
Significant news A brutal Q3 for Verbund, with 9M 26 EBITDA down 29% YoY to €1,498.5m . The hydro coefficient slumped to 0.61, the weakest water supply in c.100 years, forcing costly buybacks of...
Flutter Entertainment: Q3'26: A tough quarter, followed by another downgrade
Earnings/Sales releases Flutter delivered a weak Q3'26, with revenue and adjusted EBITDA missing consensus by 3% and 13%, respectively, prompting a second FY26 guidance cut. While US customer trends...
JC Decaux: Q326: a nice trading statement
Earnings/Sales releases JC Decaux delivered strong Q3 2026 results, with organic revenue growth of 6.6%, exceeding the 5% guidance. Digital and programmatic revenues were key growth drivers, while...
Continental: Strong EMEA Carries Q3 Beat; Raw-Material Headwind Lands in Q4
Earnings/Sales releases Continental delivered a strong Q3, with sales broadly in line with consensus and adjusted EBIT and margin clearly above consensus across all three tyre regions. Adjusted FCF...
Solvay: Middle East disruptions weigh on earnings
Earnings/Sales releases Middle East disruption weighed on the quarter. Earnings fell as Jubail stayed idle and soda ash demand softened; pass-through pricing lagged cost inflation, and high European...
Sampo: Sampo: solid 3Q26, FY26 guidance upgraded
Earnings/Sales releases Sampo has released good 3Q26 results, with a slight acceleration in Gross Written Premiums growth at constant FX and a 0.3pp y/y improvement in the combined ratio. For the...
Sacyr: 9M 2026: The cash flow machine slows
Earnings/Sales releases Sacyr reported 9M revenue growth of 11% and EBITDA growth of 9%, but operating cash flow increased only 4.5%, with cash conversion falling to 84% from 88%. Reported net profit...
Thales: Euronaval reinforces our investment thesis
Latest Our visit to EURONAVAL reinforced our positive view on Thales, particularly its ability to capture growing value from naval rearmament. With equipment accounting for c.20% of a typical naval...
Fraport: Q3 2026: Terminal 3 weighs on earnings
Earnings/Sales releases Fraport reported Q3 EBITDA 4% above consensus, but the entire beat came from €30m of one-offs. Underlying growth remains concentrated in international airports, while Frankfurt...
Marks & Spencer: Food strength offsets a slower Fashion margin recovery
Earnings/Sales releases M&S delivered H1 FY26/27 sales and adjusted PBT above consensus, supported by continued Food outperformance and a recovery in fashion revenue. However, fashion profitability...
BMW: BMW Books the Pain in Q4; FY26 Auto Margin Cut to Zero
Earnings/Sales releases BMW reported Q3 2026 group revenue and automotive EBIT above consensus, but group EBIT missed and automotive FCF swung to an outflow versus an expected inflow, as destocking...
Siltronic AG: Stronger wafer demand drives sequential recovery, but pricing improvement remains limited
Earnings/Sales releases Siltronic reported a stronger Q3 2026, with sales increasing 10.5% q-o-q to €355m, driven by higher wafer volumes. EBITDA rose to €81m, with the margin improving to 22.9%,...
Heidelberg Materials: Q3: Hungary explains most of the beat
Earnings/Sales releases Heidelberg Materials reported Q3 revenue and RCO 3.5% and 3.6% above consensus, confirmed FY26 guidance and announced another €300m of cost savings. However, the quality of the...
Demant: A good Q3, a successful launch and a market rebound
Earnings/Sales releases Following preliminary figures reported last month, Demant has released its Q3 report. As announced in Q3, hearing aids benefited from strong initial uptake of Oticon Reveal....
Novo Nordisk: Oral Wegovy proves mettle, now next generation should complement
Earnings/Sales releases The weight-loss Wegovy pill drove the Q3 beat, while most key drugs suffered from pricing and competitive pressures. With the previous outlook being overly conservative, the...
Melia Hotels International: Q3 confirmed healthy operating momentum
Earnings/Sales releases Meliá closed a transitional quarter, with revenues up 7.7% and EBITDA ex-capital gains up 4.1%. Underlying demand held up, with lfl RevPAR up 7.5%, yet reported performance...
Ahold Delhaize: Strong Q3; cyber impact is largely contained
Earnings/Sales releases Ahold Delhaize delivered a solid Q3 beat, with strong European trading and resilient US volumes despite several temporary headwinds. The October cyber incident has weighed on...
DSM-Firmenich: Q3 FY26: The upgrade was already in the price
Earnings/Sales releases DSM-Firmenich delivered another solid quarter, although the headline beat masks mixed divisional performance. fragrances remain the main growth engine, while softer TTH growth...
BioNTech: Q3 beat; sales guidance narrowed upwards; incoming CEO could shift gears
Earnings/Sales Releases BioNTech’s Q3 operational performance exceeded expectations, driven by higher outlicensing sales from Bristol-Myers Squibb. 2026 Sales Guidance was narrowed and the midpoint...
$81bn buys a lot of optimism
Target delivers turnaround and defies expectations
OVH Group: Sovereignty Starts to Pay Off
What if the price of European gas was to be decided in Tokyo?
Life after Jensen Huang
Why the euro's decline is barely reflected in company accounts
The Fed, the Other Midterm Winner
Europe gets back in the game against Wall Street
Select your edition
All financial news and data tailored to specific country editions
NORTH AMERICA
MIDDLE EAST
EUROPE
APAC